Related Experiment Videos
Translocations, fusion genes, and acute leukemia
V Saha1, B D Young, P S Freemont
1Department of Medical Oncology, St Bartholomew's Hospital, London, UK. v.saha@mds.qmw.ac.uk
Journal of Cellular Biochemistry. Supplement
|January 20, 1999
Summary
Chromosomal translocations in leukemia involve regulatory genes crucial for normal blood cell development. Their disruption, particularly involving trithorax and polycomb proteins, leads to acute leukemia by altering chromatin structure and cell maturation.
Area of Science:
- Molecular Biology
- Hematopoiesis
- Cancer Genetics
Background:
- Genes in chromosomal translocations are key to fusion protein formation in leukemia.
- These genes are regulatory and likely involved in normal hematopoietic stem cell development.
- Disruption of these genes is implicated in the pathogenesis of acute leukemia.
Purpose of the Study:
- To propose a conceptual model for acute leukemia development.
- To highlight the role of mammalian trithorax and polycomb group protein complexes.
- To elucidate the mechanisms of leukemogenesis via chromatin-mediated transcriptional regulation.
Main Methods:
- Conceptual modeling of gene interactions in hematopoiesis and leukemia.
- Analysis of functional interactions between protein complexes.
- Investigation of chromatin-mediated transcriptional activation and repression.
Main Results:
- Fusion proteins from translocations subvert normal cellular control, causing failed cell maturation and anti-apoptotic effects.
- Leukemogenesis involves disruption of regulatory genes interacting with trithorax and polycomb complexes.
- Chromatin structure and cell cycle control are central to common leukemogenesis pathways.
Conclusions:
- Understanding these regulatory networks is crucial for comprehending multipotentiality maintenance and hematopoietic cell commitment.
- Further cataloging mutation events is needed to refine models of leukemogenesis.
- Insights into these pathways offer opportunities for novel therapeutic agent development.